Shared digital NHS prescribing record could avoid nearly 1 million annual drug errors
- Details
- Category: Research
The figures, which are based on the assumption that such a system could reduce medication errors by at least 10%, and by as much as 50%, could also save £millions for the NHS, say the researchers.
Global study could change how children with multiple sclerosis are treated
- Details
- Category: Research
There are a limited number of therapies approved for children with MS, with only one considered to be of high-efficacy - meaning highly effective.
FDA approves nonsteroidal treatment for Duchenne muscular dystrophy
- Details
- Category: FDA
Reducing the side effects of breast and ovarian cancer treatment
- Details
- Category: Research
Experimental gene therapy for giant axonal neuropathy shows promise in NIH clinical trial
- Details
- Category: Research
Bayer and Thermo Fisher Scientific collaborate to increase patient access to precision cancer medicines
- Details
- Category: Bayer
Cell therapy approach harnesses the immune system in a different way to stop cancer
- Details
- Category: Research
Bacteria commonly found in the body contribute to stomach cancer
- Details
- Category: Research
Streptococcus anginosus bacteria exist alongside other germs in the mouth, throat, intestines and vagina. Occasionally, they may cause mild infections like sore throats and skin infections.
Bayer and Aignostics to collaborate on next generation precision oncology
- Details
- Category: Bayer
AstraZeneca to acquire Amolyt Pharma, expanding late-stage rare disease pipeline
- Details
- Category: AstraZeneca
The proposed acquisition will bolster the Alexion, AstraZeneca Rare Disease late-stage pipeline and expand on its bone metabolism franchise with the notable addition of eneboparatide (AZP-3601), a Phase III investigational therapeutic peptide with a novel mechanism of action designed to meet key therapeutic goals for hypoparathyroidism.